Comparison of silver nanoparticles and AgNO₃ toxic effects on Caenorhabditis elegans with a genetic disorder of copper metabolism

Abstract

BACKGROUND: Silver nanoparticles are widely used in various types of industry, but their safety for humans has not been strictly proven. The experimental data currently available on the comparison of the toxic effect of silver nanoparticles and AgNO₃ are contradictory and the question of the priority use of silver nanoparticles remains open, especially for organisms with impaired copper metabolism.

AIM: The main aim of this study is to compare the effects of silver nanoparticles and AgNO₃ on the nematode with normal and impaired copper metabolism and draw conclusions about their toxicity.

MATERIALS AND METHODS: In this work, we determined the sublethal concentration (LC₅₀) of AgNPs and AgNO₃ for H828Q nematode strain. Using the results obtained, we performed the development assay, thrashing assay and lifespan analysis of the animals.

RESULTS: It has been shown that LC₅₀ of silver nanoparticles is lower than the one for AgNO₃. Caenorhabditis elegans with impaired copper metabolism treated with silver nanoparticles have a statistically significant reduction in development, level of mobility and lifespan, comparing to animals treated with AgNO₃.

CONCLUSIONS: The results obtained allow us to conclude that the toxic effect of silver nanoparticles on C. elegans with a genetic defect in copper metabolism is higher comparing to ionic silver.

Keywords

silver nanoparticles / AgNO3 / toxicity / copper metabolism / Wilson’s disease / nematode

References

[1] Skomorokhova EA, Sankova TP, Orlov IA, et al. Size-dependent bioactivity of silver nanoparticles: antibacterial properties, influence on copper status in mice, and whole-body turnover. Nanotechnol Sci Appl. 2020;13:137–157. doi: 10.2147/NSA.S287658

[2] Skomorokhova E.A., Sankova T.P., Orlov I.A., et al. Size-dependent bioactivity of silver nanoparticles: antibacterial properties, influence on copper status in mice, and whole-body turnover // Nanotechnol Sci Appl. 2020. Vol. 13. P. 137–157. doi: 10.2147/NSA.S287658

[3] Tsang T, Davis CI, Brady DC. Copper biology. Curr Biol. 2021;31(9):R421–R427. doi: 10.1016/j.cub.2021.03.054

[4] Tsang T., Davis C.I., Brady D.C. Copper biology // Curr Biol. 2021. Vol. 31, N 9. P. R421–R427. doi: 10.1016/j.cub.2021.03.054

[5] Parisi S, Polishchuk EV, Allocca S, et al. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells. Sci Rep. 2018;8(1):6247. doi: 10.1038/s41598-018-24717-0

[6] Parisi S., Polishchuk E.V., Allocca S., et al. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells // Sci Rep. 2018. Vol. 8, N 1. P. 6247. doi: 10.1038/s41598-018-24717-0

[7] Poznański J, Sołdacki D, Czarkowska-Pączek B, et al. Cirrhotic liver of liver transplant recipients accumulate silver and co-accumulate copper. Int J Mol Sci. 2021;22(4):1782. doi: 10.3390/ijms22041782

[8] Poznański J., Sołdacki D., Czarkowska-Pączek B., et al. Cirrhotic liver of liver transplant recipients accumulate silver and co-accumulate copper // Int J Mol Sci. 2021. Vol. 22, N 4. P. 1782. doi: 10.3390/ijms22041782

[9] Polishchuk EV, Merolla A, Lichtmannegger J, et al. Activation of autophagy, observed in liver tissues from patients with wilson disease and from atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis. Gastroenterology. 2019;156(4):1173–1189.e5. doi: 10.1053/j.gastro.2018.11.032

[10] Polishchuk E.V., Merolla A., Lichtmannegger J., et al. Activation of autophagy, observed in liver tissues from patients with wilson disease and from atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis // Gastroenterology. 2019. Vol. 156, N 4. P. 1173–1189.e5. doi: 10.1053/j.gastro.2018.11.032

RIGHTS & PERMISSIONS

Eco-Vector